10 results
Newly Diagnosed Atrial Fibrillation - Management Algorithm

 • Rate Control
 • Rhythm Control
 • Anticoagulation

Matthew Ho,
Newly Diagnosed ... Atrial Fibrillation ... - Management Algorithm ... Rhythm Control • Anticoagulation ... #AFib
Newly diagnosed Atrial Fibrillation - Cardioversion and Anticoagulation Algorithm

Matthew Ho, MD PhD @MatthewHoMD

#Atrial #Fibrillation #Cardioversion #Anticoagulation
Newly diagnosed ... Atrial Fibrillation ... Algorithm Matthew ... #Fibrillation # ... #Algorithm #management
Bleeding risk calculators - HAS-BLED (atrial fibrillation) and IMPROVE (VTE prophylaxis for inpatients)
Important notes:
 • No
fibrillation) and ... validated for VTE treatment ... fibrillation • ... #Factors #Hematology ... #Diagnosis
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
Atrial Fibrillation ... control with early Afib ... (< 5% pts with afibb ... AFib #diagnosis ... #management #cardiology
Multiple Myeloma - Treatment Algorithm
a) Newly Diagnosed Myeloma: Transplant Eligible
b) Newly Diagnosed Myeloma: Transplant Ineligible

doi: 10.1038/s41408-020-00359-2

#Multiple
Multiple Myeloma - Treatment ... Algorithm a) Newly ... Diagnosed Myeloma ... #Algorithm #management ... #hematology #oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... #Anticoagulation ... #Management #Hematology ... #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... algorithm for symptomatic ... #Anticoagulation ... #Management #Hematology ... #Oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
• Triggers: ATRA ... treatment Pathophysiology ... Renal Failure Treatment ... #management #hematology ... #oncology
Behçet's Syndrome
Systemic disease associated with inflammation of multiple organs, small-vessel vasculitis and large-vessel vasculopathy
Epidemiology:
 • Young
skin injury) • Neurologic ... Vascular Disease: Arterial ... Arthritis, AS Treatment ... #management #signs ... #symptoms #rheumatology
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Splenomegaly Diagnosis ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... #diagnosis #management ... #hematology